Yano S, Shimada K
Department of Pulmonary Medicine, Shiga Prefectural Medical Center, Japan.
Jpn Circ J. 1996 Mar;60(3):185-8. doi: 10.1253/jcj.60.185.
We report here a case of vasospastic angina following the administration of Carboplatin (CBDCA) and Etoposide (VP-16) in a patient with small cell lung carcinoma. Although these drugs are commonly used to treat small cell lung carcinoma, there has been no previous report of vasospastic angina in a patient without a history of heart disease. Therefore, we should be aware of the possibility that vasospastic angina may develop even in a patient without any history of heart disease. While calcium antagonist and isosorbide dinitrate are generally helpful for preventing vasospastic angina, these drugs could not completely suppress vasospastic angina in this case.
我们在此报告一例小细胞肺癌患者在接受卡铂(CBDCA)和依托泊苷(VP - 16)治疗后发生血管痉挛性心绞痛的病例。尽管这些药物常用于治疗小细胞肺癌,但此前尚无无心脏病史患者发生血管痉挛性心绞痛的报告。因此,我们应意识到即使是无任何心脏病史的患者也可能发生血管痉挛性心绞痛。虽然钙拮抗剂和硝酸异山梨酯通常有助于预防血管痉挛性心绞痛,但在本病例中这些药物并不能完全抑制血管痉挛性心绞痛。